Skip to main content
This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.

J.P. Morgan Keeps Their Sell Rating on Fresenius Medical Care AG & Co. KGaA (0H9X)

Tipranks - Tipranks - Thu Jan 15, 3:44AM CST

J.P. Morgan analyst David Adlington maintained a Sell rating on Fresenius Medical Care AG & Co. KGaA today and set a price target of €37.40.

Claim 70% Off TipRanks Premium

According to TipRanks, Adlington is an analyst with an average return of -5.9% and a 42.09% success rate. Adlington covers the Healthcare sector, focusing on stocks such as Fresenius Medical Care AG & Co. KGaA, Koninklijke Philips N.V., and Siemens Healthineers AG.

The word on The Street in general, suggests a Hold analyst consensus rating for Fresenius Medical Care AG & Co. KGaA with a €45.41 average price target.

See today’s best-performing stocks on TipRanks >>

The company has a one-year high of €54.02 and a one-year low of €38.53. Currently, Fresenius Medical Care AG & Co. KGaA has an average volume of 729.9K.

Read More on GB:0H9X:

Disclaimer & DisclosureReport an Issue

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).